{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:41:37Z","timestamp":1793410897414,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pnpbp.2020.109945","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T10:52:55Z","timestamp":1586947975000},"page":"109945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients"],"prefix":"10.1016","volume":"101","author":[{"given":"Val\u00e9ria","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme L.","family":"Alexandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre F.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murgu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Dobrowolny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martins-de-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2020.109945_bb9067","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(00)00607-5","article-title":"Phosphatidylserine reverses reserpine-induced amnesia","volume":"404","author":"Alves","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fpsyt.2018.00209","article-title":"Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients","volume":"9","author":"Aquino","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v64n0516","article-title":"Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics","volume":"64","author":"Atmaca","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0015","article-title":"Prefrontal fatty acid composition in schizophrenia and bipolar disorder: association with reelin expression","author":"Beasley","year":"2017","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109945_bb9065","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s41467-019-09152-7","article-title":"Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism","volume":"10","author":"Bertolio","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0020","doi-asserted-by":"crossref","first-page":"7831","DOI":"10.1038\/s41598-017-08314-1","article-title":"Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies","volume":"7","author":"Capodivento","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0025","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s12035-016-9773-x","article-title":"Neuronal activity-induced sterol regulatory element binding Protein-1 (SREBP1) is disrupted in Dysbindin-null mice-potential link to cognitive impairment in schizophrenia","volume":"54","author":"Chen","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2007.01.015","article-title":"A clinical study of the association of antipsychotics with hyperlipidemia","volume":"92","author":"de Leon","year":"2007","journal-title":"Schizophr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2020.109945_bb0040","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/schbul\/sbv157","article-title":"Decreased Oligodendrocyte and neuron number in anterior hippocampal areas and the entire hippocampus in schizophrenia: a stereological postmortem study","volume":"42","author":"Falkai","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic-naive individuals with non-affective psychosis","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb9064","article-title":"Structured Clinical Interview for DSM-IV-TR Axis I disorders, Research Version, Patient Edition (SCID-I\/P)","author":"First","year":"2002","journal-title":"Biometrics Research, New York State Psychiatric Institute. New York, NY"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0050","series-title":"Interdisciplinary Praxis Guidelines: AWMF S3 Guidelines of the German Psychiatric Association for Schizophrenia","author":"Gaebel","year":"2005"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpsychires.2017.08.009","article-title":"Evidence for altered cell membrane lipid composition in postmortem prefrontal white matter in bipolar disorder and schizophrenia","volume":"95","author":"Ghosh","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2011.06.004","article-title":"Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model","volume":"131","author":"Hahn","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0065","article-title":"Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?","author":"Hellard","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0070","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0075","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0080","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0278-5846(01)00266-4","article-title":"Studies on modulation of feeding behavior by atypical antipsychotics in female mice","volume":"26","author":"Kaur","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(93)90032-C","article-title":"Erythrocyte membrane phospholipids in psychotic patients","volume":"49","author":"Keshavan","year":"1993","journal-title":"Psychiatry Res."},{"issue":"316\u201323","key":"10.1016\/j.pnpbp.2020.109945_bb0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.mp.4001332","article-title":"Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study","volume":"8","author":"Keshavan","year":"2003","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0095","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jproteome.6b00109","article-title":"New nordic diet versus average danish diet: a randomized controlled trial revealed healthy long-term effects of the new nordic diet by GC\u2013MS blood plasma metabolomics","author":"Khakimov","year":"2016","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0100","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1H669","article-title":"Effects of Risperidone on lipid profile","author":"Khalili","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/mol.108.052084","article-title":"Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists","volume":"75","author":"Knight","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.325.7358.243","article-title":"Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study","volume":"325","author":"Koro","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0269881112472568","article-title":"Increases in triglyceride levels are associated with clinical response to clozapine treatment","volume":"27","author":"Lally","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00210-010-0597-3","article-title":"Overweight induced by chronic risperidone exposure is correlated with overexpression of the SREBP-1c and FAS genes in mouse liver","volume":"383","author":"Lauressergues","year":"2011","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/YCO.0b013e32835035ca","article-title":"Life expectancy and cardiovascular mortality in persons with schizophrenia","author":"Laursen","year":"2012","journal-title":"Current Opinion in Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0130","article-title":"Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis","author":"Leppik","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-008-0156-y","article-title":"Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis","volume":"116","author":"Martins-de-Souza","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0140","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neulet.2016.02.052","article-title":"Direct affinity of dopamine to lipid membranes investigated by nuclear magnetic resonance spectroscopy","volume":"618","author":"Matam","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0145","doi-asserted-by":"crossref","first-page":"45050","DOI":"10.1038\/srep45050","article-title":"Decreased 16:0\/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia","volume":"7","author":"Matsumoto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068717","article-title":"Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics","volume":"8","author":"McEvoy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pscychresns.2011.06.017","article-title":"Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy","volume":"201","author":"Miller","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","article-title":"Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: a systematic review and meta-analysis","volume":"190","author":"Misiak","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of MetS and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.schres.2013.06.013","article-title":"Quantification of endocannabinoids in postmortem brain of schizophrenic subjects","volume":"148","author":"Muguruza","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109945_bb0175","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/14740338.2015.974549","article-title":"Weight gain and antipsychotics: a drug safety review","volume":"14","author":"Musil","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0180","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.21822","article-title":"Evidence for disruption of sphingolipid metabolism in schizophrenia","volume":"87","author":"Narayan","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0185","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.15m10467","article-title":"Effect of Aripiprazole Lauroxil on metabolic and endocrine profiles and related safety considerations among patients with acute schizophrenia","author":"Nasrallah","year":"2016","journal-title":"The Journal of Clinical Psychiatry."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0190","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0195","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrn2233","article-title":"A neuroscientist\u2019s guide to lipidomics","volume":"8","author":"Piomelli","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0920-9964(00)00189-4","article-title":"Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatology","volume":"52","author":"Ponizovsky","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0205","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1139\/jpn.0733","article-title":"Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment","volume":"32","author":"Procyshyn","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0210","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3389\/fnins.2017.00741","article-title":"The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment","volume":"11","author":"Raben","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0220","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1021\/ac500317c","article-title":"Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry","volume":"86","author":"Sarafian","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0225","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00213-015-4002-2","article-title":"Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers","volume":"232","author":"Sato","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biopsych.2004.03.019","article-title":"Altered thalamic membrane phospholipids in schizophrenia: a postmortem study","volume":"56","author":"Schmitt","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2014.12.016","article-title":"Metabolism and functions of lipids in myelin","author":"Schmitt","year":"2015","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0240","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1021\/pr800188y","article-title":"High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides","volume":"7","author":"Schwarz","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajp.2014.05.001","article-title":"Antipsychotic induced metabolic changes & treatment response: a prospective study","volume":"11","author":"Sharma","year":"2014","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-201X.2007.01687.x","article-title":"Depletion of the lipid raft constituents, sphingomyelin and ganglioside, decreases serotonin binding at human 5-HT7(a) receptors in HeLa cells","volume":"190","author":"Sj\u00f6gren","year":"2007","journal-title":"Acta Physiol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0255","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/schbul\/sbs058","article-title":"Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism","volume":"39","author":"Smesny","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0260","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2008.10.002","article-title":"The impact of mental illness on cardiac outcomes: a review for the cardiologist","volume":"132","author":"Sowden","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0265","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41537-018-0053-9","article-title":"Risk of weight gain for specific antipsychotic drugs: a meta-analysis","volume":"4","author":"Spertus","year":"2018","journal-title":"NPJ Schizophr."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.109945_bb9066","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.euroneuro.2016.07.011","article-title":"Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatment","volume":"27","author":"Steen","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11306-011-0330-3","article-title":"Double-check: validation of diagnostic statistics for PLS-DA models in metabolomics studies","volume":"8","author":"Szyma\u0144ska","year":"2012","journal-title":"Metabolomics"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.142","article-title":"Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations","volume":"6","author":"Tessier","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0285","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1021\/pr800145j","article-title":"Multilevel data analysis of a crossover designed human nutritional intervention study","volume":"7","author":"van Velzen","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0295","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pscychresns.2013.06.011","article-title":"Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study","volume":"214","author":"Weber-Fahr","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0300","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1176\/appi.ajp.2008.08081169","article-title":"Risperidone-associated increase in triglyceride levels","volume":"166","author":"Weinbrenner","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11306-009-0185-z","article-title":"Multivariate paired data analysis: multilevel PLSDA versus OPLSDA","volume":"6","author":"Westerhuis","year":"2010","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.109945_bb0310","first-page":"e263","article-title":"Accumulation of N-acylphosphatidylserines and N-acylserines in the frontal cortex in schizophrenia","volume":"1","author":"Wood","year":"2014","journal-title":"Neurotransmitter (Houst)"},{"key":"10.1016\/j.pnpbp.2020.109945_bb0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.schres.2019.08.003","article-title":"Targeted lipidomics and metabolomics evaluations of cortical neuronal stress in schizophrenia","volume":"212","author":"Wood","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.109945_bb0320","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.4238\/2015.August.10.13","article-title":"Effect of phosphatidylserine on memory in patients and rats with Alzheimer\u2019s disease","volume":"14","author":"Zhang","year":"2015","journal-title":"Genet. Mol. Res."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462030261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462030261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:54:44Z","timestamp":1759521284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462030261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":65,"alternative-id":["S027858462030261X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109945","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.25.008474","asserted-by":"object"}]},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109945","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109945"}}